Mysthera Therapeutics is a pharmaceutical company.
Mysthera Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in August 2023.
Mysthera Therapeutics's investors include Forty51 Ventures.
Mysthera Therapeutics is headquartered in Basel, Switzerland.
Mysthera Therapeutics is a pharmaceutical company.
Mysthera Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mysthera Therapeutics — Funding & Investors." VCBacked, August 21, 2023, https://www.vcbacked.co/company/mysthera-therapeutics. Accessed October 1, 2026.
VCBacked. (2023). Mysthera Therapeutics — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/mysthera-therapeutics
{{cite web |title=Mysthera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mysthera-therapeutics |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated